American Parkinson Disease Association

GLP-1 agonists are molecules that are approved for use to treat type 2 diabetes (you may be familiar with brand names like Ozempic and Weygovy). There’s research currently being done to determine the interplay of such drugs and Parkinson’s. Read more at: http://apda.link/Ozempic #Ozempic #Parkinsons #DrugEffects #GLP1 #Weygovy

Feeling unsteady? By improving your balance you can reduce your risk of falling, and also gain confidence in your ability to be out and about–or even just navigate your home more safely. This Falls Prevention Awareness Month, check out our Be Active & Beyond booklet for some simple walking, strength, and flexibility exercises. You can also give dance classes or tai chi a try - both are helpful for balance! Don’t be afraid to ask for help! If you need additional support or resources, don’t hesitate to contact APDA at 1-800-223-2732, [email protected], or visit http://apda.link/Support #Parkinsons #PDAwareness #FallsPreventionMonth #FallsPrevention #FallsPreventionAwareness

Are you approaching Medicare eligibility and feeling overwhelmed by the enrollment process? APDA is here to help. The Medicare Fall Open Enrollment is happening soon — October 15 until December 7 — and this is the time of year when you can sign up or change your Medicare coverage. Whether you’re enrolling for the first time or considering changes it can be confusing, so be sure to join us for a special session on October 2 that will provide the insights and resources you need to navigate Medicare with confidence. Register today to get expert advice, practical tips, and a Q&A to address your specific concerns. Our special guest, Maxwell Arnaud, Coordinator of Volunteers & Outreach from the Medicare Rights Center, will provide a helpful overview of the Medicare process and answer your questions about enrollment live during the program. Knowing where to start can be challenging, but we are here to help! https://lnkd.in/eYHjfQJZ #Medicare #OpenEnrollment #Broadcast #Parkinsons #Webinar

Mark your calendars! On September 17, the Parkinson’s National Day of Action, we're uniting with PD advocates and organizations around the nation to push for crucial changes in how environmental risk factors are addressed. Stay tuned for how you can #Act4PD and make sure your voice is heard! https://lnkd.in/efnyAzAc

Beyond excited to be part of this groundbreaking project aimed at better understanding levodopa-induced dyskinesia in the Latino population, leveraging the power of LARGE-PD and machine learning! Special thanks to my mentor, Ignacio Mata, and to the American Parkinson Disease Association. Fulbright Colombia

so happy to be part of the APDA family once again! This project is part of Mauricio Chaparro-Solano PhD thesis at the Cleveland Clinic Lerner College of Medicine Molecular Medicine program.

Excited to share that I’ve been awarded a fellowship from the American Parkinson Disease Association (APDA)! Huge thanks to APDA for the generous support and to my mentor, Dr. Lorenz Studer, for his guidance! Memorial Sloan Kettering Cancer Center American Parkinson Disease Association

Thrilled to receive a fellowship from the American Parkinson Disease Association Excited to get to work investigating brain dynamics underlying freezing of gait in Parkinson’s Disease

I am profoundly elated and grateful to the American Parkinson Disease Association to announce that I have joined as a member of their Board of Directors. It is a true honor to work with an organization with such impact- whose ideals are to improve the lives of those affected by this disease as well as their caregivers. This is deeply personal for me and I look forward to contributing to the mission in memory of my beautiful mother. There Is Hope In Progress!!!! #AmericanParkinsonDiseaseAssociation #APDA #healthequity #fight #parkinsons #clinicaltrials #caregiving

Subscribe to our YouTube channel! We already have over 7,000 subscribers. Be a part of the wider Parkinson’s community online. ➡️ https://lnkd.in/ehYfxMD6 #Youtube #Webinar #Free